The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain
- 30 January 2008
- journal article
- Published by Elsevier BV in Magnetic Resonance Imaging
- Vol. 26 (5), 608-617
- https://doi.org/10.1016/j.mri.2007.11.002
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Polyamine-Substituted Gadolinium Chelates: A New Class of Intracellular Contrast Agents for Magnetic Resonance Imaging of TumorsJournal of Medicinal Chemistry, 2006
- LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer MetastasesBreast Cancer Research and Treatment, 2006
- Species Dependence on Plasma Protein Binding and Relaxivity of the Gadolinium-Based MRI Contrast Agent MS-325Investigative Radiology, 2006
- New procedure for intensity and detection limit determination in spectral trace analysis: application for trace mercury by TXRFX-Ray Spectrometry, 2002
- Magnetic Resonance Imaging Detects a Specific Peptide−Protein Binding EventJournal of the American Chemical Society, 2002
- Experimental Evidence for a Second Coordination Sphere Water Molecule in the Hydration Structure of YbDTPA – Insights for a Re-Assessment of the Relaxivity Data of GdDTPAEuropean Journal of Inorganic Chemistry, 2000
- Development of a Tumor-Targeting MR Contrast Agent Using the High-Affinity Folate ReceptorInvestigative Radiology, 2000
- Prototropic and Water-Exchange Processes in Aqueous Solutions of Gd(III) ChelatesAccounts of Chemical Research, 1999
- Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1Journal of the American Chemical Society, 1996
- Antibody-magnetite nanoparticles: In vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imagingBioconjugate Chemistry, 1993